Rhodes Jason P — SEC Form 4 filings
SEC reporting owner CIK 1577014. 20 Form 4 filings on record with FilingPulse; latest filed 2026-08-17.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2024-02-20 to 2026-08-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 114 legs across 13 filings — 7,555,840 shares, $173,354,004 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 1,359,674 shares @ $25.00 ($33,991,850) in Dyne Therapeutics, Inc., filed 2026-08-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | Director | 17 | — | 114 legs · 7,555,840 sh · $173,354,004 | 4 |
| Generation Bio Co. (GBIO) | Director | 3 | — | — | 11 |
Form 4 filings — Rhodes Jason P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-17 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 268,354 @ $26.20 · Sale (S): 94,415 @ $26.20 · Sale (S): 63,643 @ $26.20 · Sale (S): 1,359,674 @ $25 · Sale (S): 478,377 @ $25 · Sale (S): 322,465 @ $25 | EDGAR |
| 2026-07-08 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 253,039 @ $22.79 · Sale (S): 127,182 @ $22.79 · Sale (S): 100,019 @ $22.79 · Sale (S): 124,379 @ $23.17 · Sale (S): 29,587 @ $23.62 · Sale (S): 62,543 @ $23.17 · +4 more | EDGAR |
| 2026-06-30 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 162,954 @ $21.28 · Sale (S): 81,903 @ $21.28 · Sale (S): 64,411 @ $21.28 · Sale (S): 102,969 @ $21.14 · Sale (S): 51,756 @ $21.14 · Sale (S): 40,702 @ $21.14 | EDGAR |
| 2026-06-26 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 77,855 @ $21.13 · Sale (S): 39,131 @ $21.13 · Sale (S): 30,774 @ $21.13 · Sale (S): 50,530 @ $21.02 · Sale (S): 25,397 @ $21.02 · Sale (S): 19,973 @ $21.02 · +3 more | EDGAR |
| 2026-06-09 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 35,152 (derivative) @ $0 | EDGAR |
| 2026-05-06 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 3,136 @ $18 · Sale (S): 6,241 @ $18 · Sale (S): 61 @ $18 · Sale (S): 2,466 @ $18 · Sale (S): 3,056 @ $18.03 · Sale (S): 6,081 @ $18.03 · +6 more | EDGAR |
| 2026-04-30 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 59,870 @ $18.38 · Sale (S): 119,115 @ $18.38 · Sale (S): 1,170 @ $18.38 · Sale (S): 47,082 @ $18.38 · Sale (S): 26 @ $19 · Sale (S): 52 @ $19 · +2 more | EDGAR |
| 2026-04-27 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 19,261 @ $19.19 · Sale (S): 38,322 @ $19.19 · Sale (S): 377 @ $19.19 · Sale (S): 15,148 @ $19.19 · Sale (S): 36,345 @ $18.48 · Sale (S): 72,310 @ $18.48 · +6 more | EDGAR |
| 2026-04-22 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 71,676 @ $20.06 · Sale (S): 142,604 @ $20.06 · Sale (S): 1,401 @ $20.06 · Sale (S): 56,368 @ $20.06 · Sale (S): 71,499 @ $19.51 · Sale (S): 142,253 @ $19.51 · +10 more | EDGAR |
| 2026-02-09 | 4 | Generation Bio Co. (GBIO) | Code (U): 711,193 · Code (U): 116,693 · Code (U): 60 · Disposition to issuer (D): 3,000 (derivative) · Disposition to issuer (D): 5,200 (derivative) · Disposition to issuer (D): 1,500 (derivative) · +3 more | EDGAR |
| 2025-06-06 | 4 | Generation Bio Co. (GBIO) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 1,111,111 @ $13.50 | EDGAR |
| 2024-11-18 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 583 @ $33.10 · Sale (S): 4 @ $33.10 · Sale (S): 123 @ $33.10 · Sale (S): 72 @ $33.10 | EDGAR |
| 2024-06-10 | 4 | Generation Bio Co. (GBIO) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 25,133 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 29,435 @ $30.05 · Sale (S): 17,099 @ $30.05 | EDGAR |
| 2024-02-28 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 136,312 @ $23.59 · Sale (S): 64,783 @ $23.98 · Sale (S): 20,205 @ $23.59 · Sale (S): 9,603 @ $23.98 · Sale (S): 11,736 @ $23.59 · Sale (S): 5,580 @ $23.98 · +12 more | EDGAR |
| 2024-02-23 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 149,337 @ $22.44 · Sale (S): 35,164 @ $23.14 · Sale (S): 119,360 @ $22.66 · Sale (S): 159,542 @ $22.70 · Sale (S): 23,648 @ $22.70 · Sale (S): 13,738 @ $22.70 | EDGAR |
| 2024-02-20 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 175,793 @ $23.88 · Sale (S): 2,113 @ $24.45 · Sale (S): 162,707 @ $23.14 · Sale (S): 166,029 @ $22.71 · Sale (S): 3,510 @ $23.40 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1577014 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →